21 Oct 2017 | 8:56 AM
 

Claris Lifesciences Ltd. Share Price Live (BSE)
0

BSE Code: 533288 | NSE Symbol:
352.20
1.45
(0.42 %)
18 Oct 2017 | 03:47 PM
Change company
  • Open (Rs)
    352.50
  • Prev. close (Rs.)
    350.75
  • High (Rs.)
    353.50
  • Low (Rs.)
    351.25
  • 52W H (Rs.)
    430.10
  • 52W L (Rs.)
    231.00
  • Volume
    35399
  • MCap (Rs in Cr.)
    1,921.89
  • Open (Rs)
  • High (Rs)
  • Low (Rs)
  • Prev. close(Rs)
  • Contracts Tra.
  • Turnover (Cr.)
  • Open Interest
  • Open Int. chg
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
20.14
Operating Margin (%)
-247.21
Gross Profit Margin (%)
-262.76
Net Profit Margin (%)
430.59
Total Debt/Equity
0.02
Dividend payout Ratio (Net Profit)
11.94
Earning Retention Ratio
193.49

News

18 Oct 2017 - 11:11:00-The Reserve Bank of India (RBI) has allowed foreign investors to raise their stake in Claris Lifesci...
21 Sep 2017 - 14:56:00-Pharma major Claris Lifesciences said that it has sold remaining 20 per cent stake in Otsuka Pharmac...
11 Aug 2017 - 15:50:00-The company reported standalone net profit of Rs 0...
11 Aug 2017 - 15:50:00-The company reported standalone net profit of Rs 0...

Announcements

12-Oct-2017
Claris Lifesciences - Outcome of Board Meeting
09-Oct-2017
Claris Lifesciences - Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosures Requirements)
09-Oct-2017
Claris Lifesciences - Compliance For The Half Year Ended September 30 2017
09-Oct-2017
Claris Lifesciences - Shareholding for the Period Ended September 30 2017
09-Oct-2017
Claris Lifesciences - Statement Of Investor Complaints For The Quarter Ended On September 30 2017

Religare Research

18 Oct 2017 | 06:00 PM
This week, we haven’t initiated fresh position and advise taking position in running recommendation....
18 Oct 2017 | 06:00 PM
Nifty managed to inch higher amid volatility, tracking favorable local cues and supportive global ...
18 Oct 2017 | 09:58 AM
The Indian rupee fell for a first time in seven sessions against the dollar, as reports U.S. Preside...
18 Oct 2017 | 09:28 AM
Gold fell on hawkish views about possible next Fed chair  Oil prices turned lower after 2-session c...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
1,80,897 3.10 62.35 -0.15
1,80,897 3.10 37.86 -0.15
0 3.10 37.86 -0.15
0 3.10 62.35 -0.15
1,10,750 2.26 23.13 -0.41

Shareholding Pattern

       
Promotors50.13%
Mutual Funds/UTI1.93%
FI/Banks0.00%
Insurance0.00%
FII25.62%
Government0.00%
Others9.41%

Peer Group

Company Intraday Graph
 Merck Ltd.
1,148.00(7.75)
3302
 Neuland Laboratories Ltd.
1,139.75(-0.44)
3578
 Kovai Medical Center and Hospital Ltd.
1,112.50(0.09)
11816
 DIL Ltd.
1,088.00(1.42)
3299

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Claris Lifesciences Ltd.-22.201.6513.20
NIFTY(S&P CNX)-6.55319.401,043.05
BSE SENSEX-33.80678.973,070.86
BSE 500-12.92572.761,510.79

Corporate Details

Key Personal
Aditya S Handa
Non Exe.Non Ind.Director
Amish Vyas
Additional Non Exe.Non Ind.Director
Anup P Shah
Non Exe. & Ind. Director
Key Address
Registered Office
Claris Corporate Headquarters Nr. Parimal Railway Crossing Ellisbridge,Ahmedabad,Gujarat

Tel:079-26563331 66309339, Fax:079-26408053

investorservices.corp@clarislifesciences.com
http://www.clarislifesciences.com
Registrar Office
Link Intime India Pvt. Ltd.
Add. :C 101 247 Park ? L.B.S. Marg Vikhroli (West)